Development of RP-HPLC method for estimation of Olmesartan Medoxomil in tablet dosage forms

Der Pharma Chemica

Volumn 3, Issue 6, 2011, Pages 208-212

  Chaitanya Prasad, M K ^a   Vidyasagar, G ^b   Sambasiva Rao, K R S ^c   Ramanjeneyulu, S ^a  

^a St Ann's college of pharmacy   (India)

^b Veerayatan Institute of Pharmacy   (India)

^c ACHARYA NAGARJUNA UNIVERSITY   (India)

Author keywords

HPLC and Tablets; Olmesartan medoxomil; Reverse phase

Indexed keywords

OLMESARTAN;

ACCURACY; ARTICLE; BULK DENSITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG DETERMINATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH MEASUREMENT; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET FORMULATION; VALIDATION PROCESS;

EID: 84855331382     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mire DE, Silfani TN, Pugsley MK. J Cardiovasc Pharmacol, 2005 46, 585-593.
2. Kobayashi N, Fujimori I, Watanabe M, Ikeda T. Anal Biochem, 2000, 287, 272-278.
3. Unger T, McInnes GT, Neutel JM, Bohm M. Drugs, 2004, 64, 2731-2739.
4. Yanagisawa H, Amemiya Y, Kanazaki T, Shimoji Y, Fujimoto K, Kitahara Y, Sada T, Mizuno M, Ikeda M, Miyamoto S, Furukawa Y, Koike H. J Med Chem, 1996, 39, 323-338.
5. Vikas VV, Shikha MNR, Santosh MY, Santosh SJ and Sagar AP. Chromatographia, 2008, 67(1-2), 147-150.
6. Liu D, Hu P, Matsushima N, Li X, Li L, Jiang J. J Chromatogr B, 2007, 856(1-2), 190-197.
7. Bari PD, Rote AR, Chromatographia, 2009, 69, 1469-1472
8. Della Grace Thomas Parambi, Molly Mathew, V Ganesan, Anila Jose, KG Revikumar. Int J Pharm Sci Rev Res, 2010, 4(3), 36-39.
9. Vachhani KH, Patel Satish A. J Appl Pharm Sci, 2011, 01 (07), 112-115.
10. Raveendra BG, Ramprasad AL, Srinivasu P, Jayachandra RP, Mustafa M. Eurasian J Anal Chem, 2010, 5(2), 145.
11. Ritesh NS, Shyam SP. Acta Pharm, 2010, 60, 13-24.
12. Pournima SP, Harinath NM, Sachin AP. Int J Pharm Pharm Sci, Vol 3, Suppl 3, 2011, 146149
13. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedure: Methodology (ICH - Q 2B) November 1996; 1-8